Literature DB >> 792404

Concentrations of erythromycin in serum and tonsil: comparison of the estolate and ethyl succinate suspensions.

C M Ginsburg, G H McCracken, M C Culbertson.   

Abstract

Concentrations of erythromycin were measured in serum and tonsil from children who had received either the estolate or ethyl succinate suspension before surgery. The in vitro assay measured total erythromycin activity against a group A beta hemolytic streptococcus. Levels of erythromycin in serum and tonsil after single and multiple doses of the estolate were significantly higher than those after administration of the ethyl succinate. The therapeutic implications of these findings are unknown.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 792404

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  7 in total

1.  Five days of erythromycin estolate versus ten days of penicillin V in the treatment of group A streptococcal tonsillopharyngitis in children. Pharyngitis Study Group.

Authors:  D Adam; H Scholz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-09       Impact factor: 3.267

2.  Current antibiotic usage II: Aminoglycosides, tetracyclines, erythromycin, vancomycin and sulphonamides.

Authors:  S M Merchant; N P Vithlani
Journal:  Indian J Pediatr       Date:  1986 Mar-Apr       Impact factor: 1.967

3.  Concentrations of erythromycin, 2'-acetyl erythromycin, and their anhydro forms in plasma and tonsillar tissue after repeated dosage of erythromycin stearate and erythromycin acistrate.

Authors:  A Gordin; P T Männistö; R Antikainen; S Savolainen; J Ylikoski; P Kokkonen; V Rauramaa
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

4.  Roxithromycin disposition in tonsils after single and repeated administrations.

Authors:  G B Galioto; G Ortisi; E Mevio; D Sassella; F Bartucci; G Privitera
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

Review 5.  Acute otitis media: diagnosis and drug therapy.

Authors:  R H Schwartz; D M Schwartz
Journal:  Drugs       Date:  1980-02       Impact factor: 9.546

6.  Minimum bactericidal concentration of sulfamethoxazole-trimethoprim for Haemophilus influenzae: correlation with prophylaxis.

Authors:  L A Kirven; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

7.  [Experience with cefaclor in the treatment of ear, nose and throat infections. Indications for cefaclor therapy (author's transl)].

Authors:  P Federspil; R Bach; C Weich; H J Wilhelm; E Tiesler; W Schätzle
Journal:  Infection       Date:  1979       Impact factor: 3.553

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.